Flagship Pioneering hires lobbyists, a first among biotech venture firms

WASHINGTON — Flagship Pioneering, the venture capital firm behind Moderna, is getting into the Washington lobbying game.

The firm has hired one of biopharma’s favorite lobbying shops to advocate on their behalf with Congress and the Biden administration, according to a new federal disclosure.

The move comes on the heels of Flagship’s recent hiring of several Washington heavyweights. The firm brought in Stephen Hahn, the FDA commissioner under President Trump. Flagship also hired Tom DiLenge, the former top policy official at the Biotechnology Innovation Organization in January. DiLenge is overseeing policy and government affairs for the venture capital firm, though he has not formally registered to lobby on Flagship’s behalf.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily intelligence on Capitol Hill and the life sciences industry — by subscribing to STAT+.

Already have an account? Log in

Individual plans

Group plans

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$20

for 3 months, then $399/year

$20 for 3 months Get Started

Then $399/year

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

To read the rest of this story subscribe to STAT+.

Subscribe

Log In